Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Parker Faxon, M.D.

Co-Author

This page shows the publications co-authored by David Faxon and Deepak Bhatt.
Connection Strength

1.641
  1. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update. Circulation. 2021 Feb 09; 143(6):583-596.
    View in: PubMed
    Score: 0.237
  2. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Circulation. 2018 07 31; 138(5):527-536.
    View in: PubMed
    Score: 0.199
  3. Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock. JACC Cardiovasc Interv. 2017 12 11; 10(23):2468-2469.
    View in: PubMed
    Score: 0.190
  4. Cangrelor Use in Cardiogenic Shock: A Single-Center Real-World Experience. JACC Cardiovasc Interv. 2017 08 28; 10(16):1712-1714.
    View in: PubMed
    Score: 0.186
  5. Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. J Am Coll Cardiol. 2017 01 31; 69(4):463-464.
    View in: PubMed
    Score: 0.177
  6. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. Circ Cardiovasc Interv. 2016 11; 9(11).
    View in: PubMed
    Score: 0.176
  7. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):522-34.
    View in: PubMed
    Score: 0.124
  8. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost. 2011 Oct; 106(4):572-84.
    View in: PubMed
    Score: 0.122
  9. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 07 09; 74(1):83-99.
    View in: PubMed
    Score: 0.053
  10. Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease. Heart. 2018 07; 104(14):1144-1147.
    View in: PubMed
    Score: 0.048
  11. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. Am J Cardiol. 2017 Aug 01; 120(3):369-373.
    View in: PubMed
    Score: 0.046
  12. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. Cochrane Database Syst Rev. 2017 May 03; 5:CD011986.
    View in: PubMed
    Score: 0.046
  13. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview. Thromb Haemost. 2014 Dec; 112(6):1080-7.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.